Axsome Therapeutics
About:
Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.
Website: http://axsome.com
Twitter/X: axsome
Description:
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where current treatment options are limited or inadequate. Axsome has a balanced portfolio of clinical development stage as well as research stage products. Axsome Therapeutics aims to become a fully integrated biopharmaceutical company that develops and commercializes differentiated products which increase the armamentarium of caregivers and improve the lives of patients. While the focus of the company is on developing its internally derived product candidates, Axsome also evaluates potential in-licensing opportunities to supplement its current portfolio.
$432M
$100M to $500M
New York, New York, United States
2012-01-01
info(AT)axsome.com
Herriot Tabuteau
251-500
2023-06-28
Public
© 2025 bioDAO.ai